Status | Study |
Not yet recruiting |
Study Name: HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer Condition: Hormone Dependent Neoplasms Breast Cancer Female Date: 2017-02-23 Interventions: Drug: Aromatase Inhibitors Aromatase Inhibitor to start im |
Completed |
Study Name: An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer Condition: Prostatic Neoplasms Neoplasms, Hormone-Dependent Date: 2008-09-05 Interventions: Drug: sunitinib 37.5 mg orally once daily, continuously, for 6 cycles of 6 consecutive weeks.Dose increa |
Terminated |
Study Name: Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer Condition: Breast Neoplasms Neoplasms, Hormone-Dependent Date: 2005-12-20 Interventions: Drug: Atamestane Drug: toremifene |
Terminated |
Study Name: The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer Condition: Breast Neoplasms Neoplasms, Hormone-Dependent Date: 2004-11-22 Interventions: Drug: Atamestane Drug: Toremifene |
Completed |
Study Name: Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer Condition: Breast Neoplasms Neoplasms, Hormone-dependent Date: 2002-08-23 Interventions: Drug: atamestane Drug: toremifene |